Overview

A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.

Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This is a trial to investigate the effectiveness and safety of [S,S]-Reboxetine in relieving chronic peripheral pain suffered by patients with diabetes. Some evidence for the effectiveness of [S,S]- Reboxetine in relieving chronic pain has been seen in 3 completed trials.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Reboxetine